Bausch Health Companies Stock Performance
| BHC Stock | CAD 8.03 0.19 2.42% |
The firm shows a Beta (market volatility) of 0.74, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Bausch Health's returns are expected to increase less than the market. However, during the bear market, the loss of holding Bausch Health is expected to be smaller as well. At this point, Bausch Health Companies has a negative expected return of -0.13%. Please make sure to confirm Bausch Health's accumulation distribution, and the relationship between the potential upside and day median price , to decide if Bausch Health Companies performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Bausch Health Companies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest abnormal performance, the Stock's fundamental indicators remain healthy and the recent disarray on Wall Street may also be a sign of long period gains for the firm investors. ...more
Last Split Factor 2:1 | Ex Dividend Date 2010-11-10 | Last Split Date 2000-10-05 |
1 | Bausch Health Examining Valuation Following a Challenging Year for Shareholders - Sahm | 11/25/2025 |
2 | Why Are Shares Of Bausch Health Up Today - Benzinga | 12/01/2025 |
3 | Is Bausch Health a Contrarian Opportunity After Its Recent Price Rebound and DCF Valuation Gap - Sahm | 12/19/2025 |
4 | Bausch Health Cos Trading Up 4.9 percent - Time to Buy - MarketBeat | 12/23/2025 |
5 | A Look At Bausch Health Valuation After Reaffirmed 2025 Guidance Ahead Of Healthcare Conference - simplywall.st | 01/14/2026 |
6 | A Look At Bausch Health Valuation As Shares Show Recent Weak Momentum - Yahoo Finance | 01/22/2026 |
7 | Phase 3 RED-C Miss for Hepatic Encephalopathy Prevention Might Change The Case For Investing In Bausch Health Companies - Sahm | 01/30/2026 |
| Begin Period Cash Flow | 962 M | |
| Total Cashflows From Investing Activities | -454 M |
Bausch |
Bausch Health Relative Risk vs. Return Landscape
If you would invest 899.00 in Bausch Health Companies on November 10, 2025 and sell it today you would lose (96.00) from holding Bausch Health Companies or give up 10.68% of portfolio value over 90 days. Bausch Health Companies is producing return of less than zero assuming 3.1704% volatility of returns over the 90 days investment horizon. Simply put, 28% of all stocks have less volatile historical return distribution than Bausch Health, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Bausch Health Target Price Odds to finish over Current Price
The tendency of Bausch Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.03 | 90 days | 8.03 | about 92.68 |
Based on a normal probability distribution, the odds of Bausch Health to move above the current price in 90 days from now is about 92.68 (This Bausch Health Companies probability density function shows the probability of Bausch Stock to fall within a particular range of prices over 90 days) .
Bausch Health Price Density |
| Price |
Predictive Modules for Bausch Health
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Bausch Health Companies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Bausch Health Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Bausch Health is not an exception. The market had few large corrections towards the Bausch Health's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Bausch Health Companies, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Bausch Health within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.28 | |
β | Beta against Dow Jones | 0.74 | |
σ | Overall volatility | 0.84 | |
Ir | Information ratio | -0.1 |
Bausch Health Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Bausch Health for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Bausch Health Companies can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Bausch Health generated a negative expected return over the last 90 days | |
| Bausch Health has high historical volatility and very poor performance | |
| Bausch Health has high likelihood to experience some financial distress in the next 2 years | |
| Bausch Health has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 9.62 B. Net Loss for the year was (72 M) with profit before overhead, payroll, taxes, and interest of 7.09 B. | |
| About 65.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Phase 3 RED-C Miss for Hepatic Encephalopathy Prevention Might Change The Case For Investing In Bausch Health Companies - Sahm |
Bausch Health Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Bausch Stock often depends not only on the future outlook of the current and potential Bausch Health's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Bausch Health's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 368 M | |
| Cash And Short Term Investments | 1.2 B |
Bausch Health Fundamentals Growth
Bausch Stock prices reflect investors' perceptions of the future prospects and financial health of Bausch Health, and Bausch Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bausch Stock performance.
| Return On Equity | 0.56 | ||||
| Return On Asset | 0.0483 | ||||
| Profit Margin | 0.04 % | ||||
| Operating Margin | 0.27 % | ||||
| Current Valuation | 30.04 B | ||||
| Shares Outstanding | 370.52 M | ||||
| Price To Book | 18.74 X | ||||
| Price To Sales | 0.30 X | ||||
| Revenue | 9.62 B | ||||
| Gross Profit | 7.09 B | ||||
| EBITDA | 2.82 B | ||||
| Net Income | (72 M) | ||||
| Cash And Equivalents | 1.18 B | ||||
| Cash Per Share | 2.49 X | ||||
| Total Debt | 21.62 B | ||||
| Debt To Equity | 906.20 % | ||||
| Current Ratio | 1.21 X | ||||
| Book Value Per Share | (2.09) X | ||||
| Cash Flow From Operations | 1.6 B | ||||
| Earnings Per Share | 1.33 X | ||||
| Market Capitalization | 2.98 B | ||||
| Total Asset | 26.52 B | ||||
| Retained Earnings | (9.82 B) | ||||
| Working Capital | (978 M) | ||||
About Bausch Health Performance
By examining Bausch Health's fundamental ratios, stakeholders can obtain critical insights into Bausch Health's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Bausch Health is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 188.34 | 132.45 | |
| Return On Tangible Assets | (0.01) | (0.01) | |
| Return On Capital Employed | 0.09 | 0.11 | |
| Return On Equity | 0.03 | 0.03 |
Things to note about Bausch Health Companies performance evaluation
Checking the ongoing alerts about Bausch Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bausch Health Companies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bausch Health generated a negative expected return over the last 90 days | |
| Bausch Health has high historical volatility and very poor performance | |
| Bausch Health has high likelihood to experience some financial distress in the next 2 years | |
| Bausch Health has high financial leverage indicating that it may have difficulties to generate enough cash to satisfy its financial obligations | |
| The company reported the revenue of 9.62 B. Net Loss for the year was (72 M) with profit before overhead, payroll, taxes, and interest of 7.09 B. | |
| About 65.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from news.google.com: Phase 3 RED-C Miss for Hepatic Encephalopathy Prevention Might Change The Case For Investing In Bausch Health Companies - Sahm |
- Analyzing Bausch Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bausch Health's stock is overvalued or undervalued compared to its peers.
- Examining Bausch Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bausch Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bausch Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bausch Health's stock. These opinions can provide insight into Bausch Health's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Bausch Health Companies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.